Karista

Karista is a venture capital firm established in 2001 and located in Paris, France. The firm specializes in incubation and early-stage investments, focusing on a diverse range of sectors including healthcare, information and communication technology, nanotechnology, and clean technology. It actively invests in startups engaged in biotechnology, medical equipment, digital technologies, deep tech, and newspace, among other areas. Karista typically directs investments ranging from €0.5 million to €5 million in companies with revenues up to €4 million. The firm primarily operates within France, particularly in the Ile-de-France region and Paris, and has supported over 90 companies over the past two decades, emphasizing partnerships with entrepreneurs who share a common vision.

Tom Beauvironnet

Investment Manager

Catherine Boule

Managing Partner, Healthcare Practice

Luca Brilliet

Investment Manager

Emmanuel Daugeras

Investment Director

Olivier Dubuisson

Co-Founder and Managing Partner

Yvan-Michel Ehkirch

Managing Partner

Baudouin Hue

Partner

Michael Thomas

Investor

Anaïs van Wynsberghe

Analyst

Benjamin Zerbib

Investment Director

143 past transactions

Exotrail

Series B in 2023
Exotrail SA, founded in 2015 and based in Palaiseau, France, specializes in developing electric propulsion systems and flight software for small satellites and their constellations. The company offers ExoMS, an innovative propulsion system designed to enable small satellite constellations to reach new orbits, and ExoOPS, a cloud-based software that aids engineers in designing and planning satellite missions. Exotrail's electric thrusters, specifically tailored for nano and micro-satellites, are utilized in various applications, including telecommunications, earth observation, and scientific research. The company's technology aims to create agile satellite constellations that enhance capabilities in these critical areas.

Ludocare

Seed Round in 2022
Ludocare focuses on developing therapeutic robots that assist patients with chronic diseases and their families. The company's innovative devices are designed to complement traditional drug treatments by providing personalized support that enhances treatment efficiency. By empowering patients, especially children, Ludocare aims to improve therapeutic compliance both quantitatively and qualitatively. This approach facilitates better disease management and helps stabilize essential treatments, ultimately contributing to improved autonomy and quality of life for patients and their families.

Vestack

Series A in 2022
Developer of proprietary software and hardware technology designed to build healthy and sustainable buildings. The company combines digital design, bio-based materials, and modular manufacturing for the construction of commercial and residential structures, enabling project developers to ensure speedy production, at a low cost, while drastically reducing the building's environmental footprint.

Leanspace

Seed Round in 2022
Leanspace is a developer of an integrated cloud platform tailored for public and private space organizations, aimed at streamlining space missions. The platform combines cloud technologies with space engineering concepts, offering a range of generic functions as services via APIs. This approach allows organizations to build their systems in-house while only developing the specific functionalities they require, thereby reducing both time and costs. By providing an innovative and collaborative framework, Leanspace enhances the agility of space organizations, enabling them to maintain control over their tools and improve their competitiveness in an increasingly complex industry.

Kranus Health

Series A in 2022
Kranus Health is a global provider for Men‘s Health Digital Therapeutics. Our therapies make millions of men live a better and longer life and enable doctors to treat their patients more efficiently.

Implicity

Series A in 2022
Implicity is a developer of a remote monitoring platform that enables the smart monitoring of patients with connected pacemakers and defibrillators. The platform utilizes artificial intelligence to sort and summarize patient data, assessing the criticality of alerts based on each patient's medical context. This innovative approach allows cardiologists and healthcare professionals to automate the remote monitoring process, consolidating patients' telepulse information into a single platform. By enhancing the efficiency of monitoring, Implicity aims to support hospital teams in delivering optimal quality care to their patients.

Humanlinker

Seed Round in 2022
Humanlinker is an innovative company that specializes in artificial intelligence-guided technology aimed at enhancing the effectiveness of revenue generation teams. Its platform facilitates the development of account-based selling strategies by providing users with AI-driven account recommendations and identifying strategic accounts that are primed for sales engagement. The technology enables sales teams to track relevant data, allowing for a comprehensive understanding of accounts and improving sales interactions. By leveraging advanced algorithms, Humanlinker's solutions support companies in optimizing their sales processes and achieving better outcomes in revenue generation.

Sitowie

Seed Round in 2022
Sitowie is a company that specializes in developing software as a service (SaaS) technology aimed at understanding and managing the degradation of buildings. Utilizing artificial intelligence and machine learning, Sitowie's platform assists clients in anticipating risks associated with the aging of structures. The tools provided by the company not only enhance the sustainability of buildings but also contribute to cost reduction and facilitate effective arbitration processes. By focusing on the preservation and sustainability of heritage properties, Sitowie aims to support clients in making informed decisions regarding building maintenance and management.

MoveUP

Seed Round in 2021
moveUP develops and commercialise digital therapeutics solutions. Its closed loop system enables high compliance, better outcome and satisfaction. It uses continuously collected data to directly personalise the treatment of the patient. Its first therapy treats orthopaedic patients undergoing a joint surgery. It has CE medical device & ISO 13485 certification.

Vestack

Series A in 2021
Developer of proprietary software and hardware technology designed to build healthy and sustainable buildings. The company combines digital design, bio-based materials, and modular manufacturing for the construction of commercial and residential structures, enabling project developers to ensure speedy production, at a low cost, while drastically reducing the building's environmental footprint.

Exotrail

Series A in 2020
Exotrail SA, founded in 2015 and based in Palaiseau, France, specializes in developing electric propulsion systems and flight software for small satellites and their constellations. The company offers ExoMS, an innovative propulsion system designed to enable small satellite constellations to reach new orbits, and ExoOPS, a cloud-based software that aids engineers in designing and planning satellite missions. Exotrail's electric thrusters, specifically tailored for nano and micro-satellites, are utilized in various applications, including telecommunications, earth observation, and scientific research. The company's technology aims to create agile satellite constellations that enhance capabilities in these critical areas.

Eyevensys

Series B in 2020
Eyevensys S.A.S. is a Paris-based company that specializes in non-viral gene therapy for ophthalmology. Founded in 2008, it focuses on developing innovative solutions to improve drug delivery methods for ocular diseases. The company utilizes its proprietary Electro-Transfection (ET) technology to administer plasmids to the ciliary muscle, allowing for the sustained release of therapeutic proteins directly into the vitreous, addressing conditions such as uveitis, age-related macular degeneration, and various retinopathies, including central retinal vein occlusion and diabetic retinopathy. Eyevensys aims to overcome the limitations of current treatment options, which often involve invasive procedures like intravitreal injections and surgeries. By enhancing compliance, ocular bioavailability, and tolerability, Eyevensys seeks to create a robust product pipeline that delivers improved clinical outcomes while minimizing the need for frequent and invasive interventions.

Eyevensys

Series B in 2020
Eyevensys S.A.S. is a Paris-based company that specializes in non-viral gene therapy for ophthalmology. Founded in 2008, it focuses on developing innovative solutions to improve drug delivery methods for ocular diseases. The company utilizes its proprietary Electro-Transfection (ET) technology to administer plasmids to the ciliary muscle, allowing for the sustained release of therapeutic proteins directly into the vitreous, addressing conditions such as uveitis, age-related macular degeneration, and various retinopathies, including central retinal vein occlusion and diabetic retinopathy. Eyevensys aims to overcome the limitations of current treatment options, which often involve invasive procedures like intravitreal injections and surgeries. By enhancing compliance, ocular bioavailability, and tolerability, Eyevensys seeks to create a robust product pipeline that delivers improved clinical outcomes while minimizing the need for frequent and invasive interventions.

Tallano

Series A in 2019
Tallano Technologie is a French company founded in 2012, based in Boulogne-Billancourt, that specializes in reducing particle emissions from vehicle braking systems. The company has developed a proprietary technology known as tamic, which effectively captures particles at the source through suction. This innovative particle collector is designed to be installed between the brake disc and pad in both private cars and public transport vehicles. Tallano Technologie positions itself as a leader in the field of particle emission reduction, addressing environmental concerns associated with vehicular braking systems.

UpFactor

Seed Round in 2019
UpFactor is an independent advisory firm based in Paris, France, specializing in the large-scale analysis of aerial land potential. Founded in 2017, the company utilizes a geographic information system that aggregates essential data for site analysis, including addresses, street widths, building heights, land use regulations, solar land registers, and protected areas. With a focus on providing comprehensive insights, UpFactor combines expertise in architecture, engineering, and law to assist clients in understanding the development potential of various sites.

TISSIUM

Series B in 2019
TISSIUM is a privately owned medical device company based in Paris, France that is dedicated to the rapid development and the commercialization of revolutionary biodegradable sealants and adhesives for wound closure in the field of surgery, with a key focus on minimally invasive surgery. TISSIUM is developing products that are non-toxic, bind strongly to tissues and deliver ‘on-demand’ wound closure within the ‘wet’ and dynamic environments in the body. The Company’s technology and products are based on world-class research and intellectual property from the laboratories of Robert Langer (MIT) and Jeff Karp (Brigham & Women’s Hospital). Gecko was founded in 2013 and is backed by leading healthcare investors Omnes Capital, CM-CIC and CapDecisif Manangement.

Acticor Biotech

Series B in 2019
Acticor Biotech SAS is a biotechnology company based in Paris, France, focused on developing therapeutic monoclonal antibodies for acute thrombotic diseases, particularly ischemic stroke. The company's lead product, Glenzocimab, is a humanized antibody aimed at addressing the critical need for new treatment options in the acute phase of stroke. Stroke affects approximately 15 million people worldwide each year, resulting in significant mortality and disability. Current treatment options are limited, with only one recommended therapy that benefits a small percentage of patients, highlighting the urgent demand for more effective solutions. Acticor Biotech was founded in 2013 and aims to provide innovative therapies that can significantly improve outcomes for stroke patients.

Acticor Biotech

Series B in 2019
Acticor Biotech SAS is a biotechnology company based in Paris, France, focused on developing therapeutic monoclonal antibodies for acute thrombotic diseases, particularly ischemic stroke. The company's lead product, Glenzocimab, is a humanized antibody aimed at addressing the critical need for new treatment options in the acute phase of stroke. Stroke affects approximately 15 million people worldwide each year, resulting in significant mortality and disability. Current treatment options are limited, with only one recommended therapy that benefits a small percentage of patients, highlighting the urgent demand for more effective solutions. Acticor Biotech was founded in 2013 and aims to provide innovative therapies that can significantly improve outcomes for stroke patients.

Incepto

Seed Round in 2019
Incepto Medical SAS develops and distributes artificial intelligence (AI) applications for medical imaging. The company’s products include Qure.ai qER, a software to help physicians in reading head CTs; Qure.ai qXR, a software to detect thorax abnormalities; Aidence Veye Chest for detecting, classifying, and tracking pulmonary nodules growth; Icometric Icobrain to monitor neurological disorders; and ScreenPoint Transpara to detect breast cancer. It also owns and operates Collective Minds Radiology, an online platform to get support on cases, share opinions, and learn from others. The company was founded in 2018 and is based in Paris, France.

Incepto

Seed Round in 2019
Incepto Medical SAS develops and distributes artificial intelligence (AI) applications for medical imaging. The company’s products include Qure.ai qER, a software to help physicians in reading head CTs; Qure.ai qXR, a software to detect thorax abnormalities; Aidence Veye Chest for detecting, classifying, and tracking pulmonary nodules growth; Icometric Icobrain to monitor neurological disorders; and ScreenPoint Transpara to detect breast cancer. It also owns and operates Collective Minds Radiology, an online platform to get support on cases, share opinions, and learn from others. The company was founded in 2018 and is based in Paris, France.

Cozycozy

Venture Round in 2019
Developer of a search engine platform intended to help users find and compare all accommodation places. The company's platform offers customizable search options, multiple filters, results displayed on a map, and tools to help find accommodation for hotels, apartments, houses, youth hostels, lodges, boats, treehouses, and more, enabling users to find satisfactory and comparable deals at a reasonable price.

Cozycozy

Venture Round in 2019
Developer of a search engine platform intended to help users find and compare all accommodation places. The company's platform offers customizable search options, multiple filters, results displayed on a map, and tools to help find accommodation for hotels, apartments, houses, youth hostels, lodges, boats, treehouses, and more, enabling users to find satisfactory and comparable deals at a reasonable price.

Algaia

Acquisition in 2019
Algaia specializes in the development, production, and commercialization of natural extracts primarily derived from seaweed. The company provides a diverse range of sustainable products and solutions tailored for the agro-nutrition, personal care, and pharmaceutical sectors. By leveraging eco-friendly biotechnologies, Algaia enhances the properties of its seaweed extracts, which serve as stabilizing and thickening agents while improving water retention. Following its acquisition of Alganact SA, Algaia has also launched a Service Division aimed at assisting customers and partners in understanding the potential applications of their seaweed biomass and characterizing their extracts. Through this comprehensive approach, Algaia positions itself as a key player in the natural extracts market.

Implicity

Seed Round in 2019
Implicity is a developer of a remote monitoring platform that enables the smart monitoring of patients with connected pacemakers and defibrillators. The platform utilizes artificial intelligence to sort and summarize patient data, assessing the criticality of alerts based on each patient's medical context. This innovative approach allows cardiologists and healthcare professionals to automate the remote monitoring process, consolidating patients' telepulse information into a single platform. By enhancing the efficiency of monitoring, Implicity aims to support hospital teams in delivering optimal quality care to their patients.

Misakey

Seed Round in 2019
Misakey SAS is a company based in Paris, France, that specializes in developing a personal data protection platform aimed at managing digital identities. Founded in 2018, Misakey's platform enables users to access and control their personal data across various social media and online platforms. It allows individuals to recover their data, request updates, and initiate deletions or restrictions, thereby empowering them to reclaim control over their personal information. Additionally, the platform facilitates collaboration for webmasters to integrate applications and create compliant websites, enhancing overall data security and management.

Admo.tv

Series B in 2019
Admo.tv is the best TV analytics platform that helps TV & radio advertisers to measure and optimise the online impact of their offline investments. Admo.tv optimises, in average, about 30% the R.O.I. of its clients by providing the finest analysis in terms of incremental visits and conversion of their media investments. Admo.tv is a start-up that has offices in Paris and operates in more than 12 different countries worldwide. Admo.tv optimise every day the offline investments of the best advertising agencies (Dentsu Aegis, Havas…) and top-tier brands such as Accor, Allianz, Ford, Meetic, La Redoute, and more.

Admo.tv

Series B in 2019
Admo.tv is the best TV analytics platform that helps TV & radio advertisers to measure and optimise the online impact of their offline investments. Admo.tv optimises, in average, about 30% the R.O.I. of its clients by providing the finest analysis in terms of incremental visits and conversion of their media investments. Admo.tv is a start-up that has offices in Paris and operates in more than 12 different countries worldwide. Admo.tv optimise every day the offline investments of the best advertising agencies (Dentsu Aegis, Havas…) and top-tier brands such as Accor, Allianz, Ford, Meetic, La Redoute, and more.

Acticor Biotech

Series B in 2018
Acticor Biotech SAS is a biotechnology company based in Paris, France, focused on developing therapeutic monoclonal antibodies for acute thrombotic diseases, particularly ischemic stroke. The company's lead product, Glenzocimab, is a humanized antibody aimed at addressing the critical need for new treatment options in the acute phase of stroke. Stroke affects approximately 15 million people worldwide each year, resulting in significant mortality and disability. Current treatment options are limited, with only one recommended therapy that benefits a small percentage of patients, highlighting the urgent demand for more effective solutions. Acticor Biotech was founded in 2013 and aims to provide innovative therapies that can significantly improve outcomes for stroke patients.

Acticor Biotech

Series B in 2018
Acticor Biotech SAS is a biotechnology company based in Paris, France, focused on developing therapeutic monoclonal antibodies for acute thrombotic diseases, particularly ischemic stroke. The company's lead product, Glenzocimab, is a humanized antibody aimed at addressing the critical need for new treatment options in the acute phase of stroke. Stroke affects approximately 15 million people worldwide each year, resulting in significant mortality and disability. Current treatment options are limited, with only one recommended therapy that benefits a small percentage of patients, highlighting the urgent demand for more effective solutions. Acticor Biotech was founded in 2013 and aims to provide innovative therapies that can significantly improve outcomes for stroke patients.

Wisebatt

Seed Round in 2018
Wisebatt SAS, founded in 2016 and based in Chatou, France, specializes in web-based simulation software tailored for electronic engineers working on Internet of Things (IoT) devices. The platform allows users to create virtual prototypes and conduct power analysis and optimization of battery-powered devices early in the design process. By providing rapid access to complex modeling results that would typically take weeks, Wisebatt enhances the efficiency and effectiveness of hardware and software designers, as well as service providers. The technology is rooted in over 15 years of academic research, enabling users to make informed decisions regarding cost, battery life, and performance, ultimately leading to the development of more reliable and sustainable electronic solutions.

Wisebatt

Seed Round in 2018
Wisebatt SAS, founded in 2016 and based in Chatou, France, specializes in web-based simulation software tailored for electronic engineers working on Internet of Things (IoT) devices. The platform allows users to create virtual prototypes and conduct power analysis and optimization of battery-powered devices early in the design process. By providing rapid access to complex modeling results that would typically take weeks, Wisebatt enhances the efficiency and effectiveness of hardware and software designers, as well as service providers. The technology is rooted in over 15 years of academic research, enabling users to make informed decisions regarding cost, battery life, and performance, ultimately leading to the development of more reliable and sustainable electronic solutions.

TRiCares

Series B in 2018
TRiCares is a medical device company, devoted to developing a catheter-based valve replacement system for minimal invasive treatment of tricuspid valve regurgitation.

TRiCares

Series B in 2018
TRiCares is a medical device company, devoted to developing a catheter-based valve replacement system for minimal invasive treatment of tricuspid valve regurgitation.

Serious Factory

Series A in 2018
Serious Factory is a Paris-based company founded in 2007 that specializes in developing innovative training and sales support simulators. The company's primary offering is the Virtual Training Suite, a Software-as-a-Service solution that enhances traditional learning processes across various industries, including aerospace, automotive, banking, construction, energy, luxury, retail, medical, and telecommunications. Serious Factory leverages expertise in instructional engineering and gamification to create effective training programs that encompass digital learning modules, serious games, blended learning, and practical simulations. Their technology enables businesses to design, distribute, and regularly update educational content while also monitoring skill development. Serious Factory operates through a network of partner resellers across Europe, Asia, and North America.

AppScho

Seed Round in 2018
AppScho, SAS is a Paris-based company founded in 2014 that specializes in developing mobile application software for the higher education sector. The application centralizes various intranet information, enabling students to easily access their schedules, grades, school events, and internship opportunities. It provides functionalities for students to preview upcoming courses, including classroom details and instructor information, while also sending notifications for any class changes. Additionally, the platform allows educational institutions and teachers to communicate with students, monitor engagement levels, and analyze academic performance. By streamlining access to essential information, AppScho aims to enhance student engagement and simplify communication within educational environments.

Pherecydes Pharma

Series B in 2018
Pherecydes Pharma SA is a biotechnology company based in Romainville, France, established in 2006. It specializes in the research and development of lytic bacteriophages, which are natural predators of bacteria, for therapeutic and diagnostic applications, particularly in addressing antibiotic resistance. The company has developed several banks of bacteriophages, including a collection targeting Escherichia coli. Pherecydes Pharma is engaged in innovative approaches to personalized phage therapy, aiming to treat bacterial infections by launching multicenter European trials, such as those evaluating phage therapy for infected burn wounds. This therapeutic strategy allows for the detection and treatment of a wide range of bacterial infections, including multi-resistant and emergent strains, without affecting human cells.

Acticor Biotech

Series A in 2018
Acticor Biotech SAS is a biotechnology company based in Paris, France, focused on developing therapeutic monoclonal antibodies for acute thrombotic diseases, particularly ischemic stroke. The company's lead product, Glenzocimab, is a humanized antibody aimed at addressing the critical need for new treatment options in the acute phase of stroke. Stroke affects approximately 15 million people worldwide each year, resulting in significant mortality and disability. Current treatment options are limited, with only one recommended therapy that benefits a small percentage of patients, highlighting the urgent demand for more effective solutions. Acticor Biotech was founded in 2013 and aims to provide innovative therapies that can significantly improve outcomes for stroke patients.

Precogs

Venture Round in 2017
Precogs is a company specializing in business analytics solutions, focusing on the electronic components sector. Founded in 2011 and based in Paris, France, Precogs provides tools for supply risk management, enterprise resource planning (ERP), and procurement monitoring. Their key products include CogWatch, a big data predictive tool designed to enhance decision-making, and Cog Margin, a platform that aids in component pricing. The company primarily assists EMS, OEM, and ODM businesses in sourcing competitive prices for electronic components in real-time, thereby streamlining procurement processes and optimizing cost-efficiency.

PayinTech

Venture Round in 2017
PayinTech SAS, founded in 2010 and based in Paris, France, specializes in cashless payment solutions utilizing NFC technology. The company initially developed a payment system using wristbands and terminals for a student bar, which later evolved into a scalable solution for large events. PayinTech gained recognition as the provider of the first fully cashless festival in Europe in 2012, managing payments for 14,000 attendees. The company has since grown into a leading player in the fintech sector, securing significant funding to enhance research and development. Its software integrates monetary transactions with management, inventory, and customer relationship tools, primarily serving the entertainment and tourism industries. PayinTech's solutions are implemented in various venues, including resorts, amusement parks, and events across 16 countries, enabling clients to streamline financial operations, boost on-site revenues, and enhance user experiences.

Acticor Biotech

Seed Round in 2017
Acticor Biotech SAS is a biotechnology company based in Paris, France, focused on developing therapeutic monoclonal antibodies for acute thrombotic diseases, particularly ischemic stroke. The company's lead product, Glenzocimab, is a humanized antibody aimed at addressing the critical need for new treatment options in the acute phase of stroke. Stroke affects approximately 15 million people worldwide each year, resulting in significant mortality and disability. Current treatment options are limited, with only one recommended therapy that benefits a small percentage of patients, highlighting the urgent demand for more effective solutions. Acticor Biotech was founded in 2013 and aims to provide innovative therapies that can significantly improve outcomes for stroke patients.

AppScho

Seed Round in 2017
AppScho, SAS is a Paris-based company founded in 2014 that specializes in developing mobile application software for the higher education sector. The application centralizes various intranet information, enabling students to easily access their schedules, grades, school events, and internship opportunities. It provides functionalities for students to preview upcoming courses, including classroom details and instructor information, while also sending notifications for any class changes. Additionally, the platform allows educational institutions and teachers to communicate with students, monitor engagement levels, and analyze academic performance. By streamlining access to essential information, AppScho aims to enhance student engagement and simplify communication within educational environments.

Ugloo

Venture Round in 2017
Ugloo, offers an indestructible data storage solution. This secondary storage solution allows you to upgrade the available space in the infrastructure as a virtual rack. Since Ugloo reuses the available space in the infrastructure, the company does not need additional investments and retains 100% governance over its data.

Nexdot

Venture Round in 2016
Nexdot SAS, established in 2016 and based in Romainville, France, specializes in the development, manufacturing, and application of semiconductor nanocrystals known as Quantum Dots (QDs). The company is recognized as a leader in producing nanoplatelets, a form of 2D nanosheet Quantum Dots that exhibit enhanced properties. Originating as a spin-off from a prestigious academic laboratory in Paris, Nexdot leverages over a decade of research experience in nanomaterials. The company has invested significantly in research and development, resulting in proprietary techniques for creating colloidal Quantum Dots and Nanoplatelets with precise shape and composition. These innovative materials are poised to transform various industries, including displays, lighting, energy storage, detectors, and bio-imaging. Additionally, Nexdot is exploring quantum encapsulation technology to enhance the usability of its quantum plates, facilitating their integration into existing production processes while adhering to regulatory standards. The company’s team comprises highly skilled scientists and experienced executives, focusing on innovation and effective management.

Restlet

Convertible Note in 2016
Restlet is providing the fastest and easiest API-First Platform as a Service that developers and non-developers working on API projects can use. It includes a comprehensive, well-integrated set of capabilities to design, document, test and host APIs. Thanks to Restlet Platform, enterprises of all sizes can leverage APIs to make cloud, mobile, web or IoT applications easier to build, maintain and secure. To encourage growth of the API development community, Restlet Founders also build and maintain Restlet Framework, one of the world’s most widely used open source REST API frameworks. Named a Cool Vendor in Specialized PaaS by Gartner in 2015, founding member of the Open API Initiative, Restlet has its headquarters in San Mateo, California with its engineering office in Nantes, France.

TRiCares

Seed Round in 2016
TRiCares is a medical device company, devoted to developing a catheter-based valve replacement system for minimal invasive treatment of tricuspid valve regurgitation.

Linkfluence

Series C in 2016
Linkfluence is a social media intelligence company that focuses on analyzing online conversations across various platforms, including social networks, blogs, and forums, to create business opportunities for brands. Its flagship product, the Radarly Product Suite, is a user-friendly, multilingual software-as-a-service solution designed to monitor, measure, and engage with social media content effectively. Radarly aids in reputation management, influencer engagement, community management evaluation, crisis detection, and best practice identification. Linkfluence also supports companies in customizing the tool to meet specific needs such as performance analysis, brand perception audits, and trend research. With over 200 prominent clients in Europe, Linkfluence empowers organizations to enhance their social strategies by leveraging social data intelligence. The company is backed by several venture capital firms, indicating strong investor confidence in its innovative approach to social media analysis.

NAVYA

Series B in 2016
Navya SA is a prominent French company specializing in autonomous vehicle technology and smart shared mobility solutions. Founded in 2014 and headquartered in Villeurbanne, France, Navya develops, manufactures, and services a range of driverless electric vehicles, including autonomous shuttles and cabs. The company primarily caters to municipalities, industrial sites, universities, theme parks, and airports, and its products are available in the United States, EMEA, and Asia-Pacific regions. Navya has been a pioneer in the autonomous mobility sector, launching its first shuttle, the AUTONOM®SHUTTLE, in 2015, with over 100 units produced and sold in multiple countries. The AUTONOM®CAB, introduced in 2017, is set to undergo road tests soon. With a workforce of more than 200 employees in France and the United States, Navya combines advanced robotic and digital technologies to deliver innovative mobility solutions.

Stootie

Series A in 2016
Stootie is a buyer-focused classifieds platform. It's mobile. It's local. And it's quick. Really quick! This is the tool you use to get that phone power outlet you forgot when you're working in a Starbucks. Or pretty much anything else. Anywhere. Anytime. The keywords of Stootie are : marketplace, P2P business, local, mobile, realtime, platform. Stootie is currently available on iOS and Android.

Playtem

Venture Round in 2016
Playtem is a team led by passionate entrepreneurs. Their goal is to create the future of advertising thanks to their new in-game native formats. They believe that having an impactful format for the brands while maintaining an optimal user experience is possible.

Stereolabs

Venture Round in 2016
Stereolabs Inc. specializes in developing 3D depth sensing technology aimed at enhancing autonomous robotics and augmented reality applications. Founded in 2006 and headquartered in San Francisco, California, with an additional office in Sheung Wan, Hong Kong, the company offers the ZED Stereo Camera, which utilizes passive stereo vision for depth perception. This technology enables machines to understand and interact with their environments in a manner similar to human vision. Stereolabs is also known for Linq, a mixed reality headset that allows users to engage in interactive gaming experiences by merging real and virtual worlds. The ZED camera has gained widespread adoption among developers and is increasingly utilized by major gaming companies for mixed-reality capture in virtual and augmented reality games.

Nexdot

Venture Round in 2016
Nexdot SAS, established in 2016 and based in Romainville, France, specializes in the development, manufacturing, and application of semiconductor nanocrystals known as Quantum Dots (QDs). The company is recognized as a leader in producing nanoplatelets, a form of 2D nanosheet Quantum Dots that exhibit enhanced properties. Originating as a spin-off from a prestigious academic laboratory in Paris, Nexdot leverages over a decade of research experience in nanomaterials. The company has invested significantly in research and development, resulting in proprietary techniques for creating colloidal Quantum Dots and Nanoplatelets with precise shape and composition. These innovative materials are poised to transform various industries, including displays, lighting, energy storage, detectors, and bio-imaging. Additionally, Nexdot is exploring quantum encapsulation technology to enhance the usability of its quantum plates, facilitating their integration into existing production processes while adhering to regulatory standards. The company’s team comprises highly skilled scientists and experienced executives, focusing on innovation and effective management.

Comiteo

Venture Round in 2016
Comitéo, founded in 2008, designs and innovative services adapted to works councils. Comitéo supports a simple idea: to facilitate the mission of the elected by offering a web platform and mobile application, highly configurable for access to technology, culture, recreation, management and communication.

Restlet

Convertible Note in 2016
Restlet is providing the fastest and easiest API-First Platform as a Service that developers and non-developers working on API projects can use. It includes a comprehensive, well-integrated set of capabilities to design, document, test and host APIs. Thanks to Restlet Platform, enterprises of all sizes can leverage APIs to make cloud, mobile, web or IoT applications easier to build, maintain and secure. To encourage growth of the API development community, Restlet Founders also build and maintain Restlet Framework, one of the world’s most widely used open source REST API frameworks. Named a Cool Vendor in Specialized PaaS by Gartner in 2015, founding member of the Open API Initiative, Restlet has its headquarters in San Mateo, California with its engineering office in Nantes, France.

Sevenhugs

Seed Round in 2016
Sevenhugs Inc. specializes in ultra-wideband (UWB) systems for indoor positioning and orientation tracking, providing software solutions tailored for smartphone, IoT device, and automotive manufacturers. Founded in 2014 and based in San Francisco, the company is known for its Smart Remote, which is designed to simplify the control of various smart home devices and entertainment systems through a single adaptive interface. This universal remote allows users to manage their TV, music, and lighting seamlessly, enhancing the smart home experience. Sevenhugs also offers features such as secure localization, data fusion, and low power consumption to facilitate precise tracking and control. As of October 2020, Sevenhugs operates as a subsidiary of Qorvo, Inc.

Bnbsitter

Series A in 2016
Bnbsitter is a Paris-based company that provides concierge rental services for vacation hosts. Established in 2013, the company facilitates the booking of essential welcome services, allowing hosts to efficiently manage guest check-ins and check-outs, as well as rental cleaning, all within a two-minute timeframe. Bnbsitter aims to assist hosts who may be busy, traveling, or otherwise unable to personally greet their guests, ensuring that visitors receive a warm welcome. In addition to these services, the company offers a comprehensive online platform that includes features such as tenant search, lease signing, and maintenance management, catering to the needs of both hosts and guests in the temporary rental market.

TISSIUM

Series A in 2016
TISSIUM is a privately owned medical device company based in Paris, France that is dedicated to the rapid development and the commercialization of revolutionary biodegradable sealants and adhesives for wound closure in the field of surgery, with a key focus on minimally invasive surgery. TISSIUM is developing products that are non-toxic, bind strongly to tissues and deliver ‘on-demand’ wound closure within the ‘wet’ and dynamic environments in the body. The Company’s technology and products are based on world-class research and intellectual property from the laboratories of Robert Langer (MIT) and Jeff Karp (Brigham & Women’s Hospital). Gecko was founded in 2013 and is backed by leading healthcare investors Omnes Capital, CM-CIC and CapDecisif Manangement.

Melusyn

Seed Round in 2016
Melusyn offers an interactive platform that enables film product crews to keep track of and optimize their schedules. It enables teams to communicate with each other; keep track of decorations, casting, and costumes; keep track of time; and more. Melusyn is based in Paris, France.

NAVYA

Venture Round in 2016
Navya SA is a prominent French company specializing in autonomous vehicle technology and smart shared mobility solutions. Founded in 2014 and headquartered in Villeurbanne, France, Navya develops, manufactures, and services a range of driverless electric vehicles, including autonomous shuttles and cabs. The company primarily caters to municipalities, industrial sites, universities, theme parks, and airports, and its products are available in the United States, EMEA, and Asia-Pacific regions. Navya has been a pioneer in the autonomous mobility sector, launching its first shuttle, the AUTONOM®SHUTTLE, in 2015, with over 100 units produced and sold in multiple countries. The AUTONOM®CAB, introduced in 2017, is set to undergo road tests soon. With a workforce of more than 200 employees in France and the United States, Navya combines advanced robotic and digital technologies to deliver innovative mobility solutions.

Restlet

Convertible Note in 2015
Restlet is providing the fastest and easiest API-First Platform as a Service that developers and non-developers working on API projects can use. It includes a comprehensive, well-integrated set of capabilities to design, document, test and host APIs. Thanks to Restlet Platform, enterprises of all sizes can leverage APIs to make cloud, mobile, web or IoT applications easier to build, maintain and secure. To encourage growth of the API development community, Restlet Founders also build and maintain Restlet Framework, one of the world’s most widely used open source REST API frameworks. Named a Cool Vendor in Specialized PaaS by Gartner in 2015, founding member of the Open API Initiative, Restlet has its headquarters in San Mateo, California with its engineering office in Nantes, France.

MOPeasy

Venture Round in 2015
MOPeasy, ecomobility operator, provides solutions for car sharing of electric vehicules and others, car pooling and access and reservations for charging stations, all in one platform. THE community solution adapted to companies, cities and collective habitats. MOPeasy turns charging stations into mobility stations, operates from 1 to 50 vehicules fleet for a Company. and from 1 station in Rural Communities up to 100 stations across a territory. Interoperable, MOPeasy's platform brings ecomobility solutions for Smart cities.

NAVYA

Seed Round in 2015
Navya SA is a prominent French company specializing in autonomous vehicle technology and smart shared mobility solutions. Founded in 2014 and headquartered in Villeurbanne, France, Navya develops, manufactures, and services a range of driverless electric vehicles, including autonomous shuttles and cabs. The company primarily caters to municipalities, industrial sites, universities, theme parks, and airports, and its products are available in the United States, EMEA, and Asia-Pacific regions. Navya has been a pioneer in the autonomous mobility sector, launching its first shuttle, the AUTONOM®SHUTTLE, in 2015, with over 100 units produced and sold in multiple countries. The AUTONOM®CAB, introduced in 2017, is set to undergo road tests soon. With a workforce of more than 200 employees in France and the United States, Navya combines advanced robotic and digital technologies to deliver innovative mobility solutions.

Mitricares

Seed Round in 2015
MITRICARES aims to develop and market an implantable medical device for percutaneous treatment of tricuspid valves failed. The young company has already realized a first prototype successfully tested several times on the big animal. This new system would address a major public health problem, tricuspid insufficiency, which affects 4 million people in Europe and the USA, with a poor prognosis in the short term.

SetKeeper

Venture Round in 2015
SetKeeper develops an application platform designed to streamline the physical production process for audiovisual projects, including films, television shows, and broadcasts. The platform offers features such as document watermarking and distribution, script sides, and an electronic signature service, all aimed at facilitating operational and technical management. By leveraging innovative technologies, SetKeeper enhances the production landscape, allowing clients to efficiently coordinate their projects and optimize schedules while ensuring the security and integrity of their materials.

Aterovax

Seed Round in 2015
Aterovax is an in vitro diagnostic company focused on developing innovative solutions for the prediction, diagnosis, and prevention of cardiovascular disease. With a unique understanding of atherosclerosis, Aterovax creates diagnostic tests that assess the level of atherosclerotic plaque development in patients. These tests aim to provide insights into cardiovascular risk, enabling more effective management and intervention strategies for individuals at risk of cardiovascular conditions.

TRiCares

Seed Round in 2015
TRiCares is a medical device company, devoted to developing a catheter-based valve replacement system for minimal invasive treatment of tricuspid valve regurgitation.

Actvt

Seed Round in 2015
Actvt Inc. specializes in innovative video editing technology aimed at transforming long videos into engaging short-form content. The company offers a product portfolio that includes Activity, a user-friendly app available on iOS and Android, which assists users in selecting highlights from their footage to automatically generate concise edits. Additionally, Actvt provides Showdown.cc, an in-game replay plugin designed for game developers, allowing players to create, share, and explore gameplay videos. Through these offerings, Actvt seeks to enhance the social video experience by making video creation more accessible and enjoyable.

Prestodiag

Series A in 2015
Prestodiag develops, manufactures and sells innovative solutions for rapid detection of bacteria. Their analytical solutions are based on an innovative optics technology called Surface Plasmon Resonance imaging and allow detection and identification of pathogenic bacteria such as Salmonella, Listeria or E.coli. They provide users with a result in just a few hours instead of 1 to several days. Their market is primarily the food safety sector, and also on medical and environmental applications.

Melusyn

Seed Round in 2015
Melusyn offers an interactive platform that enables film product crews to keep track of and optimize their schedules. It enables teams to communicate with each other; keep track of decorations, casting, and costumes; keep track of time; and more. Melusyn is based in Paris, France.

Eyevensys

Seed Round in 2015
Eyevensys S.A.S. is a Paris-based company that specializes in non-viral gene therapy for ophthalmology. Founded in 2008, it focuses on developing innovative solutions to improve drug delivery methods for ocular diseases. The company utilizes its proprietary Electro-Transfection (ET) technology to administer plasmids to the ciliary muscle, allowing for the sustained release of therapeutic proteins directly into the vitreous, addressing conditions such as uveitis, age-related macular degeneration, and various retinopathies, including central retinal vein occlusion and diabetic retinopathy. Eyevensys aims to overcome the limitations of current treatment options, which often involve invasive procedures like intravitreal injections and surgeries. By enhancing compliance, ocular bioavailability, and tolerability, Eyevensys seeks to create a robust product pipeline that delivers improved clinical outcomes while minimizing the need for frequent and invasive interventions.

RED Technologies

Seed Round in 2015
RED Technologies specializes in developing innovative spectrum-sharing solutions aimed at addressing the growing demand for accessible and affordable wireless services. Their cloud-based spectrum access system operates within a three-tier hierarchy, facilitating effective spectrum sharing while ensuring the protection of users across different tiers. By offering end-to-end dynamic spectrum sharing solutions, RED Technologies contributes to addressing spectrum shortages, thereby supporting broader wireless market growth and fostering positive changes in both the economy and society.

OpenOcean

Seed Round in 2015
OpenOcean is an early-stage venture capital firm founded in 2008 and headquartered in Helsinki, Finland, with additional offices in London and Amsterdam. The firm specializes in investing in technology companies across Europe, particularly in sectors such as cybersecurity, fintech, artificial intelligence, software, and cloud technology. OpenOcean typically leads or co-leads Series A funding rounds, often involving investments around €5 million. With a strong entrepreneurial foundation, the firm actively collaborates with founders to help build and scale innovative, data-driven software solutions.

English Attack

Series A in 2015
English Attack is an online platform dedicated to English language learning, targeting independent teachers, schools, universities, language institutes, and companies in Greece and Cyprus. Founded in 2009 and based in Paris, the platform offers a unique approach by using digital entertainment to enhance language acquisition. Its offerings include interactive video exercises based on popular movies, TV series, music, and current events, along with visual dictionaries and engaging language games that help users practice vocabulary and comprehension skills. The service is available through subscription models for individual learners, multi-user licenses for educational institutions, and language training programs for companies. English Attack emphasizes a fun and engaging learning experience, positioning itself within the growing $35 billion English language learning market.

Serious Factory

Seed Round in 2015
Serious Factory is a Paris-based company founded in 2007 that specializes in developing innovative training and sales support simulators. The company's primary offering is the Virtual Training Suite, a Software-as-a-Service solution that enhances traditional learning processes across various industries, including aerospace, automotive, banking, construction, energy, luxury, retail, medical, and telecommunications. Serious Factory leverages expertise in instructional engineering and gamification to create effective training programs that encompass digital learning modules, serious games, blended learning, and practical simulations. Their technology enables businesses to design, distribute, and regularly update educational content while also monitoring skill development. Serious Factory operates through a network of partner resellers across Europe, Asia, and North America.

VitamFero

Series C in 2015
VitamFero SA is a biotechnology company based in Angers, France, that specializes in the development and marketing of prophylactic agents, particularly vaccines and neonatal immunostimulants, aimed at treating various infectious diseases. Founded in 2005, the company utilizes its patented Toxo Mic1-3KO technology to create innovative vaccines targeting Apicomplexe parasites. Its product line includes vaccines such as VFOtx-251 for ovine toxoplasmosis, VFOne-273 for bovine neosporosis, and VFOlh-211 for canine leishmaniasis and equine protozoal myeloencephalitis. With a focus primarily on veterinary healthcare, VitamFero is dedicated to addressing the challenges posed by these infectious agents, thereby improving animal health outcomes.

PayinTech

Seed Round in 2015
PayinTech SAS, founded in 2010 and based in Paris, France, specializes in cashless payment solutions utilizing NFC technology. The company initially developed a payment system using wristbands and terminals for a student bar, which later evolved into a scalable solution for large events. PayinTech gained recognition as the provider of the first fully cashless festival in Europe in 2012, managing payments for 14,000 attendees. The company has since grown into a leading player in the fintech sector, securing significant funding to enhance research and development. Its software integrates monetary transactions with management, inventory, and customer relationship tools, primarily serving the entertainment and tourism industries. PayinTech's solutions are implemented in various venues, including resorts, amusement parks, and events across 16 countries, enabling clients to streamline financial operations, boost on-site revenues, and enhance user experiences.

Stootie

Seed Round in 2015
Stootie is a buyer-focused classifieds platform. It's mobile. It's local. And it's quick. Really quick! This is the tool you use to get that phone power outlet you forgot when you're working in a Starbucks. Or pretty much anything else. Anywhere. Anytime. The keywords of Stootie are : marketplace, P2P business, local, mobile, realtime, platform. Stootie is currently available on iOS and Android.

Sevenhugs

Seed Round in 2015
Sevenhugs Inc. specializes in ultra-wideband (UWB) systems for indoor positioning and orientation tracking, providing software solutions tailored for smartphone, IoT device, and automotive manufacturers. Founded in 2014 and based in San Francisco, the company is known for its Smart Remote, which is designed to simplify the control of various smart home devices and entertainment systems through a single adaptive interface. This universal remote allows users to manage their TV, music, and lighting seamlessly, enhancing the smart home experience. Sevenhugs also offers features such as secure localization, data fusion, and low power consumption to facilitate precise tracking and control. As of October 2020, Sevenhugs operates as a subsidiary of Qorvo, Inc.

Sevenhugs

Acquisition in 2015
Sevenhugs Inc. specializes in ultra-wideband (UWB) systems for indoor positioning and orientation tracking, providing software solutions tailored for smartphone, IoT device, and automotive manufacturers. Founded in 2014 and based in San Francisco, the company is known for its Smart Remote, which is designed to simplify the control of various smart home devices and entertainment systems through a single adaptive interface. This universal remote allows users to manage their TV, music, and lighting seamlessly, enhancing the smart home experience. Sevenhugs also offers features such as secure localization, data fusion, and low power consumption to facilitate precise tracking and control. As of October 2020, Sevenhugs operates as a subsidiary of Qorvo, Inc.

Open Ocean

Seed Round in 2015
Open Ocean is an innovative company based in Brest and Paris, which conceives since 2011 online decision-making solutions for industrial marine activities. Their highly qualified team of oceanographers, trained in the best research oceanographic institutes of the world (UPMC, IFREMER, University of Washington) is specialized in high resolution modelling, statistical analysis and data mining.

Pherecydes Pharma

Series A in 2014
Pherecydes Pharma SA is a biotechnology company based in Romainville, France, established in 2006. It specializes in the research and development of lytic bacteriophages, which are natural predators of bacteria, for therapeutic and diagnostic applications, particularly in addressing antibiotic resistance. The company has developed several banks of bacteriophages, including a collection targeting Escherichia coli. Pherecydes Pharma is engaged in innovative approaches to personalized phage therapy, aiming to treat bacterial infections by launching multicenter European trials, such as those evaluating phage therapy for infected burn wounds. This therapeutic strategy allows for the detection and treatment of a wide range of bacterial infections, including multi-resistant and emergent strains, without affecting human cells.

Restlet

Convertible Note in 2014
Restlet is providing the fastest and easiest API-First Platform as a Service that developers and non-developers working on API projects can use. It includes a comprehensive, well-integrated set of capabilities to design, document, test and host APIs. Thanks to Restlet Platform, enterprises of all sizes can leverage APIs to make cloud, mobile, web or IoT applications easier to build, maintain and secure. To encourage growth of the API development community, Restlet Founders also build and maintain Restlet Framework, one of the world’s most widely used open source REST API frameworks. Named a Cool Vendor in Specialized PaaS by Gartner in 2015, founding member of the Open API Initiative, Restlet has its headquarters in San Mateo, California with its engineering office in Nantes, France.

Web Geo Services

Seed Round in 2014
Web Geo Services SAS, founded in 2009 and headquartered in Montpellier, France, specializes in online mapping and geolocation applications. The company provides location-based software as a service (SaaS) technology tailored for various industries, including retail, e-commerce, travel, hospitality, banking, and automotive. By leveraging Google Maps, Web Geo Services assists businesses in enhancing customer engagement and driving conversions through effective digital systems. The company has established itself as a leading partner of Google Cloud in Europe and has successfully collaborated with more than 400 large companies. Its flagship product, Woosmap, is recognized for enabling developers to integrate advanced location intelligence features into mobile applications and websites. Web Geo Services focuses on delivering innovative solutions that empower clients to optimize online customer journeys and boost revenue.

Playtem

Venture Round in 2014
Playtem is a team led by passionate entrepreneurs. Their goal is to create the future of advertising thanks to their new in-game native formats. They believe that having an impactful format for the brands while maintaining an optimal user experience is possible.

Precogs

Seed Round in 2014
Precogs is a company specializing in business analytics solutions, focusing on the electronic components sector. Founded in 2011 and based in Paris, France, Precogs provides tools for supply risk management, enterprise resource planning (ERP), and procurement monitoring. Their key products include CogWatch, a big data predictive tool designed to enhance decision-making, and Cog Margin, a platform that aids in component pricing. The company primarily assists EMS, OEM, and ODM businesses in sourcing competitive prices for electronic components in real-time, thereby streamlining procurement processes and optimizing cost-efficiency.

Rool'in

Seed Round in 2014
Rool'in offers innovative, practical and ecological solutions in the field of bicycle mobility.

Neelogy

Seed Round in 2013
Neelogy SA, established in 2008 and based in Cachan, France, specializes in the development and marketing of advanced electromagnetic sensors. The company focuses on non-remanence magnetic sensors, which are designed for the precise measurement of both alternating and continuous electrical currents. Neelogy's innovative sensors cater to various applications, including energy metering, AC/DC energy conversion, electrical energy storage, and real-time fault detection and diagnostics. By providing space-saving, maintenance-free, and recalibration-free solutions, Neelogy enables clients to achieve accurate measurements of direct current components. As of July 2019, Neelogy operates as a subsidiary of Safran Electrical & Power S.A.S.

Axess Vision Technology

Series B in 2013
Axess Vision Technology S.A. designs disposable sterile endoscopes. It offers bronchoscopy, urology, animal health, and other interface products. The company was founded in 2006 and is based in Saint-Pierre-des-Corps, France.

TISSIUM

Series A in 2013
TISSIUM is a privately owned medical device company based in Paris, France that is dedicated to the rapid development and the commercialization of revolutionary biodegradable sealants and adhesives for wound closure in the field of surgery, with a key focus on minimally invasive surgery. TISSIUM is developing products that are non-toxic, bind strongly to tissues and deliver ‘on-demand’ wound closure within the ‘wet’ and dynamic environments in the body. The Company’s technology and products are based on world-class research and intellectual property from the laboratories of Robert Langer (MIT) and Jeff Karp (Brigham & Women’s Hospital). Gecko was founded in 2013 and is backed by leading healthcare investors Omnes Capital, CM-CIC and CapDecisif Manangement.

Aterovax

Seed Round in 2013
Aterovax is an in vitro diagnostic company focused on developing innovative solutions for the prediction, diagnosis, and prevention of cardiovascular disease. With a unique understanding of atherosclerosis, Aterovax creates diagnostic tests that assess the level of atherosclerotic plaque development in patients. These tests aim to provide insights into cardiovascular risk, enabling more effective management and intervention strategies for individuals at risk of cardiovascular conditions.

Stereolabs

Seed Round in 2013
Stereolabs Inc. specializes in developing 3D depth sensing technology aimed at enhancing autonomous robotics and augmented reality applications. Founded in 2006 and headquartered in San Francisco, California, with an additional office in Sheung Wan, Hong Kong, the company offers the ZED Stereo Camera, which utilizes passive stereo vision for depth perception. This technology enables machines to understand and interact with their environments in a manner similar to human vision. Stereolabs is also known for Linq, a mixed reality headset that allows users to engage in interactive gaming experiences by merging real and virtual worlds. The ZED camera has gained widespread adoption among developers and is increasingly utilized by major gaming companies for mixed-reality capture in virtual and augmented reality games.

Restlet

Seed Round in 2013
Restlet is providing the fastest and easiest API-First Platform as a Service that developers and non-developers working on API projects can use. It includes a comprehensive, well-integrated set of capabilities to design, document, test and host APIs. Thanks to Restlet Platform, enterprises of all sizes can leverage APIs to make cloud, mobile, web or IoT applications easier to build, maintain and secure. To encourage growth of the API development community, Restlet Founders also build and maintain Restlet Framework, one of the world’s most widely used open source REST API frameworks. Named a Cool Vendor in Specialized PaaS by Gartner in 2015, founding member of the Open API Initiative, Restlet has its headquarters in San Mateo, California with its engineering office in Nantes, France.

AlephD

Series A in 2013
AlephD SAS provides publishers with real-time optimization strategies together with business intelligence solutions. It offers YieldEngine, a real-time yield management solution for AppNexus; InstantPredict, which addresses publishers’ constant need to decide what source of revenue to prioritize; and InventoryLab, an integrated software suite to help publishers to make decisions based on data analysis and business intelligence tools. The company was incorporated in 2012 and is based in Paris, France. As of January 25, 2016, AlephD SAS operates as a subsidiary of AOL Inc.

Fidzup

Seed Round in 2013
Fidzup is a Paris-based company that specializes in indoor localization and local marketing solutions for brick-and-mortar businesses. Established in 2011, Fidzup has developed an innovative platform that integrates Wi-Fi and GPS technology to track mobile user behavior within retail spaces. This technology allows retailers to analyze consumer movements and interactions, enabling them to send personalized advertisements directly to customers' mobile devices when they enter a store. By leveraging real-time data and analytics, Fidzup aims to enhance customer engagement and optimize marketing strategies for physical retail environments.

Fidzup

Angel Round in 2013
Fidzup is a Paris-based company that specializes in indoor localization and local marketing solutions for brick-and-mortar businesses. Established in 2011, Fidzup has developed an innovative platform that integrates Wi-Fi and GPS technology to track mobile user behavior within retail spaces. This technology allows retailers to analyze consumer movements and interactions, enabling them to send personalized advertisements directly to customers' mobile devices when they enter a store. By leveraging real-time data and analytics, Fidzup aims to enhance customer engagement and optimize marketing strategies for physical retail environments.

Nanoe

Seed Round in 2013
Nanoe Sarl, founded in 2008 and based in Chilly-Mazarin, France, specializes in the development and manufacturing of nanopowders tailored for the ceramic industry. The company provides a range of products including ready-to-sinter nanopowders, ready-to-press granulates, slurries, and customized solutions that cater to the needs of technical ceramics manufacturers. Nanoe's offerings include nano-scale ceramics made from materials such as alumina, zirconia, and zirconia toughened alumina, enabling clients to access high-quality nanopowders at competitive prices. By leveraging advancements in nanotechnology, Nanoe aims to enhance the manufacturing capabilities of its customers in the ceramics sector.

e(ye)BRAIN

Series B in 2012
e(ye)BRAIN SA is a medical company based in Paris, France, that specializes in the development and manufacturing of eye trackers aimed at diagnosing neurological and psychiatric diseases. Founded in 2008, the company offers two primary products, EyeBrain T1 and EyeBrain T2. The EyeBrain T1 device records eye movements, while the EyeBrain T2 captures both eye and head movements using advanced algorithms. The data collected from these devices is analyzed through the MeyeEval software, which aids in clinical assessments. In addition to its core products, e(ye)BRAIN provides clinical research tools and offers advisory and support services, enhancing the functional exploration of the brain in both healthy and diseased states.

WeCook WeCare

Seed Round in 2012
WeCook is the new companion for a better nutrition and a better health. It uses his meal planner and the Alantaya's technology in order to offer the best high personnalized nutritionnal recommandation and the best coaching with dieteticians. High personnalized nutritionnal recommandation goes from Cancer to pregnancy.

Stryng

Seed Round in 2012
Stryng is a developer of an AI-powered client messaging platform designed to enhance communication between businesses and their customers. The platform integrates live chat, audio and video communication, and collaboration tools, allowing companies to manage all customer interactions in a centralized location. By automatically classifying messages from customers, Stryng helps mobile client-facing professionals streamline their communication, ultimately increasing sales and improving the overall customer experience.

Plasmabiotics

Seed Round in 2012
SAS PlasmaBiotics operates as a biotechnology company that designs, manufactures and markets generators of cold plasma nitrogen for medical disinfection. The company was incorporated in 2011 and is based in Evry, France. As of August 1, 2018, SAS PlasmaBiotics operates as a subsidiary of HOYA Corporation.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.